aprovel
sanofi winthrop industrie - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal-product regimen.
aprovel 150 mg tablet
sanofi-aventis south africa (pty) ltd - tablet - see ingredients - each tablet contains irbesartan 150 mg
aprovel 300 mg tablet
sanofi-aventis south africa (pty) ltd - tablet - see ingredients - each tablet contains irbesartan 300 mg
aprovel 150mg film-coated tablets
sanofi-aventis (malaysia) sdn. bhd. - irbesartan -
aprovel 150mg tablets
sanofi - irbesartan - tablet - 150mg
aprovel 300mg tablets
sanofi - irbesartan - tablet - 300mg
aprovel film-coated tablet 150 mg
sanofi-aventis singapore pte. ltd. - irbesartan - tablet, film coated - 150.00 mg - irbesartan 150.00 mg
aprovel film-coated tablet 300 mg
sanofi-aventis singapore pte. ltd. - irbesartan - tablet, film coated - 300.00 mg - irbesartan 300.00 mg
aprovel 75 mg 28 comprimits recoberts
aprovel 300mg film-coated tablet
sanofi-aventis (malaysia) sdn. bhd. - irbesartan -